[HTML][HTML] Maternal diabetes impairs insulin and IGF-1 receptor expression and signaling in human placenta
A Tumminia, NM Scalisi, A Milluzzo, G Ettore… - Frontiers in …, 2021 - frontiersin.org
Background Maternal high blood glucose during pregnancy increases the risk for both
maternal and fetal adverse outcomes. The mechanisms underlying the regulator effects of …
maternal and fetal adverse outcomes. The mechanisms underlying the regulator effects of …
Maternal Diabetes Impairs Insulin and IGF-1 Receptor Expression and Signaling in Human Placenta
A Tumminia, NM Scalisi, A Milluzzo… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Maternal high blood glucose during pregnancy increases the risk for both
maternal and fetal adverse outcomes. The mechanisms underlying the regulator effects of …
maternal and fetal adverse outcomes. The mechanisms underlying the regulator effects of …
[PDF][PDF] Maternal Diabetes Impairs Insulin and IGF-1 Receptor Expression and Signaling in Human Placenta
A Tumminia, NM Scalisi, A Milluzzo… - Front. Endocrinol. 12 …, 2021 - researchgate.net
Background: Maternal high blood glucose during pregnancy increases the risk for both
maternal and fetal adverse outcomes. The mechanisms underlying the regulator effects of …
maternal and fetal adverse outcomes. The mechanisms underlying the regulator effects of …
Maternal Diabetes Impairs Insulin and IGF-1 Receptor Expression and Signaling in Human Placenta.
A Tumminia, NM Scalisi, A Milluzzo, G Ettore… - Frontiers in …, 2021 - europepmc.org
Background Maternal high blood glucose during pregnancy increases the risk for both
maternal and fetal adverse outcomes. The mechanisms underlying the regulator effects of …
maternal and fetal adverse outcomes. The mechanisms underlying the regulator effects of …
[HTML][HTML] Maternal Diabetes Impairs Insulin and IGF-1 Receptor Expression and Signaling in Human Placenta
A Tumminia, NM Scalisi, A Milluzzo… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
Background Maternal high blood glucose during pregnancy increases the risk for both
maternal and fetal adverse outcomes. The mechanisms underlying the regulator effects of …
maternal and fetal adverse outcomes. The mechanisms underlying the regulator effects of …
[PDF][PDF] Maternal Diabetes Impairs Insulin and IGF-1 Receptor Expression and Signaling in Human Placenta
A Tumminia, NM Scalisi, A Milluzzo, G Ettore… - Front. Endocrinol. 12 …, 2021 - iris.unict.it
Background: Maternal high blood glucose during pregnancy increases the risk for both
maternal and fetal adverse outcomes. The mechanisms underlying the regulator effects of …
maternal and fetal adverse outcomes. The mechanisms underlying the regulator effects of …
[PDF][PDF] Maternal Diabetes Impairs Insulin and IGF-1 Receptor Expression and Signaling in Human Placenta
A Tumminia, NM Scalisi, A Milluzzo, G Ettore… - Front. Endocrinol. 12 …, 2021 - iris.unict.it
Background: Maternal high blood glucose during pregnancy increases the risk for both
maternal and fetal adverse outcomes. The mechanisms underlying the regulator effects of …
maternal and fetal adverse outcomes. The mechanisms underlying the regulator effects of …